Back to DRIEHAUS CAPITAL MANAGEMENT LLC DRIEHAUS CAPITAL MANAGEMENT LLC

CRNXCRNX
25 quarters

Position history for DRIEHAUS CAPITAL MANAGEMENT LLCDRIEHAUS CAPITAL MANAGEMENT LLC's holdings in CRINETICS PHARMACEUTICALS IN

DRIEHAUS CAPITAL MANAGEMENT LLC holds 6.5M shares of CRNX (CRINETICS PHARMACEUTICALS IN), worth $241.9M as of 2026-Q2. The position was increased (+1.1% shares). CRNX represents 1.4% of DRIEHAUS CAPITAL MANAGEMENT LLC's portfolio.

Current Value

$241.9M

Current Shares

6.5M

Total Value Change

+$226.3M

Total Shares Change

+5.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
6.5M
+1.1%
$241.9M1.4%$37.42
49
2026-Q1
Increased
6.4M
+0.1%
$232.3M1.7%$36.32
48
2025-Q4
Decreased
6.4M
-1.4%
$297.3M2.0%$46.55
0
2025-Q3
Increased
6.5M
+1.3%
$270M1.9%$41.65
49
2025-Q2
Increased
6.4M
+2.6%
$184.1M1.5%$28.76
49
2025-Q1
Increased
6.2M
+1.6%
$209.3M2.0%$33.54
53
2024-Q4
Increased
6.1M
+4.3%
$314M2.6%$51.13
55
2024-Q3
Decreased
5.9M
-3.7%
$300.7M2.6%$51.10
0
2024-Q2
Increased
6.1M
+16.9%
$273.8M2.6%$44.79
61
2024-Q1
Increased
5.2M
+3.7%
$244.6M2.4%$46.81
55
2023-Q4
Decreased
5M
-1.8%
$179.3M2.2%$35.58
0
2023-Q3
Decreased
5.1M
-3.1%
$152.6M2.0%$29.74
0
2023-Q2
Increased
5.3M
+0.2%
$95.5M1.2%$18.02
47
2023-Q1
Decreased
5.3M
-6.0%
$84.9M1.2%$16.06
0
2022-Q4
Decreased
5.6M
-0.1%
$102.9M1.5%$18.30
0
2022-Q3
Increased
5.6M
+2.9%
$110.6M1.7%$19.64
49
2022-Q2
Increased
5.5M
+10.7%
$102.1M1.7%$18.65
52
2022-Q1
Increased
4.9M
+3.1%
$108.5M1.3%$21.95
49
2021-Q4
Increased
4.8M
+59.9%
$136.2M1.4%$28.41
68
2021-Q3
Increased
3M
+10.7%
$63.1M0.7%$21.05
46
2021-Q2
Increased
2.7M
+35.1%
$51M0.7%$18.85
54
2021-Q1
Increased
2M
+37.8%
$30.6M0.5%$15.28
45
2020-Q4
Increased
1.5M
+66.2%
$20.5M0.3%$14.11
50
2020-Q3
Decreased
874,842
-1.3%
$13.7M0.3%$15.67
0
2020-Q2
New
886,762
-
$15.5M0.4%$17.52
47

Other major holders of CRNX: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used